ISO 27001 Certificate
SOC 1 Type I Certificate
SOC 2 Type II Certificate
PCI DSS
HIPAA
RGPD
Internal validation & live display
Multiple badges & continuous verification
Faster underwriting decisions
ISOSOC2 Type 1SOC2 Type 2PCI DSSHIPAAGDPR

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Roche A.I CyberSecurity Scoring

Roche

Company Details

Linkedin ID:

roche

Employees number:

99,293

Number of followers:

3,687,367

NAICS:

541714

Industry Type:

Biotechnology Research

Homepage:

roche.com

IP Addresses:

26

Company ID:

ROC_1940626

Scan Status:

Completed

AI scoreRoche Risk Score (AI oriented)

Between 800 and 849

https://images.rankiteo.com/companyimages/roche.jpeg
Roche Biotechnology Research
Updated:
  • Powered by our proprietary A.I cyber incident model
  • Insurance preferes TPRM score to calculate premium
globalscoreRoche Global Score (TPRM)

XXXX

https://images.rankiteo.com/companyimages/roche.jpeg
Roche Biotechnology Research
  • Instant access to detailed risk factors
  • Benchmark vs. industry & size peers
  • Vulnerabilities
  • Findings

Roche Company CyberSecurity News & History

Past Incidents
0
Attack Types
0
No data available
Ailogo

Roche Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

🔒
Incident Predictions locked
Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

🔒
A.I. Risk Score Predictions locked
Access Monitoring Plan
statics

Underwriter Stats for Roche

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Roche in 2025.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Roche in 2025.

Incident Types Roche vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Roche in 2025.

Incident History — Roche (X = Date, Y = Severity)

Roche cyber incidents detection timeline including parent company and subsidiaries

Roche Company Subsidiaries

SubsidiaryImage

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Loading...
similarCompanies

Roche Similar Companies

The National Institutes of Health

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an

ICON plc

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality

Agilent Technologies

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product

Thermo Fisher Scientific

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an

bioMérieux

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v

Amgen

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s

Syneos Health

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w

Eurofins

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to eva

newsone

Roche CyberSecurity News

October 23, 2025 07:00 AM
Microsoft has stopped all support and updates for Windows 10

However, users can extend their security updates for one year by going to Settings, clicking "Update & Security," and then selecting Windows...

October 20, 2025 07:00 AM
Microsoft ends support for Windows 10, prompting cybersecurity experts to advise users to upgrade

For machines that cannot run Windows 11, purchasing new systems that meet modern security standards is recommended.

October 14, 2025 07:00 AM
Cybersecurity jobs available right now: October 14, 2025

First Citizens Bank | USA | Remote – No longer accepting applications. As a Cyber Security Analyst, you will be responsible for developing...

October 07, 2025 07:00 AM
Discord Joins List of Companies Hit by CRM Breaches After Attack on Its Zendesk Implementation

Discord has confirmed a significant security breach of its third-party customer service platform. That platform was Zendesk, according to...

September 05, 2025 01:26 PM
Armen Grigoryan discussed economic opportunities for unblocking regional communications in Paris

On September 5, during a working visit to Paris, Armen Grigoryan, the Secretary of the Security Council of Armenia, held a meeting with Nicolas Roche,...

September 04, 2025 07:00 AM
LISW 2025: Maritime Cyber Defence & Risk Intelligence (London)

Cyber threats, geopolitical tension, and evolving environmental/data regulations are converging to create unprecedented operational risk for...

August 28, 2025 07:00 AM
CISA's New SBOM Guidelines Get Mixed Reviews

Updated federal agency guidelines for software bills of materials (SBOM) were recently released by the US Cybersecurity and Infrastructure...

August 28, 2025 07:00 AM
The 10 Best Pregnancy Skincare Products Recommended By Dermatologists

The best pregnancy skincare products use gentle, fragrance-free, and effective ingredients, such as ceramides and hyaluronic acid.

August 12, 2025 07:00 AM
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline

Swiss biotech Mabylon secured €31.8 million in funding to advance its peanut allergy antibody program and early-stage pipeline.

faq

Frequently Asked Questions

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.

Roche CyberSecurity History Information

Official Website of Roche

The official website of Roche is http://www.roche.com/.

Roche’s AI-Generated Cybersecurity Score

According to Rankiteo, Roche’s AI-generated cybersecurity score is 835, reflecting their Good security posture.

How many security badges does Roche’ have ?

According to Rankiteo, Roche currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Does Roche have SOC 2 Type 1 certification ?

According to Rankiteo, Roche is not certified under SOC 2 Type 1.

Does Roche have SOC 2 Type 2 certification ?

According to Rankiteo, Roche does not hold a SOC 2 Type 2 certification.

Does Roche comply with GDPR ?

According to Rankiteo, Roche is not listed as GDPR compliant.

Does Roche have PCI DSS certification ?

According to Rankiteo, Roche does not currently maintain PCI DSS compliance.

Does Roche comply with HIPAA ?

According to Rankiteo, Roche is not compliant with HIPAA regulations.

Does Roche have ISO 27001 certification ?

According to Rankiteo,Roche is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Industry Classification of Roche

Roche operates primarily in the Biotechnology Research industry.

Number of Employees at Roche

Roche employs approximately 99,293 people worldwide.

Subsidiaries Owned by Roche

Roche presently has no subsidiaries across any sectors.

Roche’s LinkedIn Followers

Roche’s official LinkedIn profile has approximately 3,687,367 followers.

NAICS Classification of Roche

Roche is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Roche’s Presence on Crunchbase

Yes, Roche has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/roche.

Roche’s Presence on LinkedIn

Yes, Roche maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/roche.

Cybersecurity Incidents Involving Roche

As of December 05, 2025, Rankiteo reports that Roche has not experienced any cybersecurity incidents.

Number of Peer and Competitor Companies

Roche has an estimated 4,428 peer or competitor companies worldwide.

Roche CyberSecurity History Information

How many cyber incidents has Roche faced ?

Total Incidents: According to Rankiteo, Roche has faced 0 incidents in the past.

What types of cybersecurity incidents have occurred at Roche ?

Incident Types: The types of cybersecurity incidents that have occurred include .

Incident Details

What are the most common types of attacks the company has faced ?

Additional Questions

cve

Latest Global CVEs (Not Company-Specific)

Description

Sigstore Timestamp Authority is a service for issuing RFC 3161 timestamps. Prior to 2.0.3, Function api.ParseJSONRequest currently splits (via a call to strings.Split) an optionally-provided OID (which is untrusted data) on periods. Similarly, function api.getContentType splits the Content-Type header (which is also untrusted data) on an application string. As a result, in the face of a malicious request with either an excessively long OID in the payload containing many period characters or a malformed Content-Type header, a call to api.ParseJSONRequest or api.getContentType incurs allocations of O(n) bytes (where n stands for the length of the function's argument). This vulnerability is fixed in 2.0.3.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description

Monkeytype is a minimalistic and customizable typing test. In 25.49.0 and earlier, there is improper handling of user input which allows an attacker to execute malicious javascript on anyone viewing a malicious quote submission. quote.text and quote.source are user input, and they're inserted straight into the DOM. If they contain HTML tags, they will be rendered (after some escaping using quotes and textarea tags).

Risk Information
cvss4
Base: 7.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

SysReptor is a fully customizable pentest reporting platform. Prior to 2025.102, there is a Stored Cross-Site Scripting (XSS) vulnerability allows authenticated users to execute malicious JavaScript in the context of other logged-in users by uploading malicious JavaScript files in the web UI. This vulnerability is fixed in 2025.102.

Risk Information
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
Description

Taiko Alethia is an Ethereum-equivalent, permissionless, based rollup designed to scale Ethereum without compromising its fundamental properties. In 2.3.1 and earlier, TaikoInbox._verifyBatches (packages/protocol/contracts/layer1/based/TaikoInbox.sol:627-678) advanced the local tid to whatever transition matched the current blockHash before knowing whether that batch would actually be verified. When the loop later broke (e.g., cooldown window not yet passed or transition invalidated), the function still wrote that newer tid into batches[lastVerifiedBatchId].verifiedTransitionId after decrementing batchId. Result: the last verified batch could end up pointing at a transition index from the next batch (often zeroed), corrupting the verified chain pointer.

Risk Information
cvss4
Base: 8.0
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:U/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A flaw has been found in youlaitech youlai-mall 1.0.0/2.0.0. Affected is the function getById/updateAddress/deleteAddress of the file /mall-ums/app-api/v1/addresses/. Executing manipulation can lead to improper control of dynamically-identified variables. The attack can be executed remotely. The exploit has been published and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 6.5
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
cvss3
Base: 6.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Access Data Using Our API

SubsidiaryImage

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=roche' -H 'apikey: YOUR_API_KEY_HERE'

What Do We Measure ?

revertimgrevertimgrevertimgrevertimg
Incident
revertimgrevertimgrevertimgrevertimg
Finding
revertimgrevertimgrevertimgrevertimg
Grade
revertimgrevertimgrevertimgrevertimg
Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network Security

Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)

Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)

Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat Intelligence

Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Top LeftTop RightBottom LeftBottom Right
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
Users Love Us Badge